These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 24873948
1. BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK. Poller DN, Glaysher S, Agrawal A, Caldera S, Kim D, Yiangou C. J Clin Pathol; 2014 Aug; 67(8):684-9. PubMed ID: 24873948 [Abstract] [Full Text] [Related]
3. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P. Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615 [Abstract] [Full Text] [Related]
13. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis. Trimboli P, Scappaticcio L, Treglia G, Guidobaldi L, Bongiovanni M, Giovanella L. Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566 [Abstract] [Full Text] [Related]
14. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH. Clin Cancer Res; 2004 Apr 15; 10(8):2761-5. PubMed ID: 15102681 [Abstract] [Full Text] [Related]
15. Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples. Capelli L, Marfisi C, Puccetti M, Saragoni L, De Paola F, Zaccaroni A, Chiadini E, Gagliardi L, Ferretti G, Zoli W, Ulivi P. Cytopathology; 2015 Oct 15; 26(5):297-302. PubMed ID: 25123949 [Abstract] [Full Text] [Related]
17. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S. Ann Pathol; 2010 Aug 15; 30(4):252-62. PubMed ID: 20837233 [Abstract] [Full Text] [Related]
18. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method. Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH. Surgery; 2015 Feb 15; 157(2):354-61. PubMed ID: 25616949 [Abstract] [Full Text] [Related]
19. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ, Kim EK, Kwak JY. Pathol Res Pract; 2015 Sep 15; 211(9):671-6. PubMed ID: 26187369 [Abstract] [Full Text] [Related]